Patent classifications
G01N2333/415
Anti-gliadin antibodies, encoding nucleic acids and methods of detecting gliadin
The present invention provides anti-gliadin antibodies and antibody fragments, and polypeptides encoding the antibodies or fragment. Also disclosed are methods and Kits for the use of such antibodies, fragments, or polypeptides in detection of gliadin. Further provided are heavy chain and light chain variable sequences and associated sequences of complementarity-determining regions (CDRs).
BRASSICA GAT EVENT AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF
Compositions and methods related to transgenic glyphosate tolerant Brassica plants are provided. Specifically, the present invention provides Brassica plants having a DP-073496-4 event which imparts tolerance to glyphosate. The Brassica plant harboring the DP-073496-4 event at the recited chromosomal location comprises genomic/transgene junctions within SEQ ID NO: 2 or with genomic/transgene junctions as set forth in SEQ ID NO: 12 and/or 13. The characterization of the genomic insertion site of the event provides for an enhanced breeding efficiency and enables the use of molecular markers to track the transgene insert in the breeding populations and progeny thereof. Various methods and compositions for the identification, detection, and use of the event are provided.
Non-antibody ligands for detecting target proteins
The invention relates generally to synthetic non-antibody protein scaffolds (synNAPS) that differentially detect or quantitate a target insecticidal protein in a complex biological matrix comprising the target protein and a non-target insecticidal protein and to methods of using the synNAPS in immunoassays, and more particularly to monoclonal antibodies and immunoassays for the differential detection and quantitation of a wild-type crystal protein, such as a wild-type-Cry1Ab, from Bacillus thuringiensis and hybrid crystal proteins, which comprise all or a significant portion of the wild-type Cry protein in complex biological samples comprising both the wild-type Cry protein and one or more of the hybrid Cry proteins.
Rust resistance gene
The present invention relates to new transporter polypeptides, and genes encoding therefor, which can be used to confer upon a plant resistance to one or more biotrophic fungal pathogens.
Nanoparticles adsorbed with gliadin molecules
The present disclosure generally relates to nanoparticles adsorbed with gliadin molecules. In addition, the present disclosure relates to methods of preparing the nanoparticles adsorbed with gliadin molecules and methods of using said nanoparticles including detecting anti-gliadin 5 antibodies in a sample, diagnosing gluten-related disorders, and other applications.
Apparatus for real time and on line analysis of the agricultural crop
The apparatus (1) for agricultural crop analysis, comprises: a light source (2) for sending light radiation towards a crop; a plurality of sensors (21) for acquiring light radiation reflected by the crop and a plurality of filtering elements (22) adapted to enable complete passage only of light having frequencies within a predetermined passband. The filtering elements (22) have passbands that differ from each other and each filtering element (22) is functionally coupled with a respective sensor (21) in such a manner that the latter receives only light radiation that has traversed the former.
METABONOMICS-BASED TOBACCO LEAF MILDEWING IDENTIFICATION METHOD
A metabonomics-based tobacco leaf mildewing identification method, which comprises: obtaining tobacco leaf samples of the same variety, and carrying out artificial mildewing on a certain amount of tobacco leaf samples to obtain mildewed tobacco leaves; measuring volatile and semi-volatile components in the tobacco leaves before and after the tobacco leaf samples are mildewed by adopting a solid phase microextraction-gas chromatography-mass spectrometry method; performing data processing on the collected mass spectrum data to obtain the proportion content of different types of compounds in the mildewed sample and the normal sample, and further obtaining the change difference of the content of volatile compounds in the tobacco leaf sample before and after mildewing; and establishing a tobacco leaf mildewing identification model according to the discrimination variables. The accuracy and efficiency of tobacco mildew identification can be improved, the quality of tobacco shreds is improved.
SYSTEMS AND METHODS FOR ALLERGEN DETECTION
Disclosed herein are methods of allergen testing and IgG depletion. In some embodiments, testing for IgE antibodies specific for an allergen may be improved by first depleting IgG in a sample. In some embodiments, IgG may be depleted using Biotinylated Protein G (bPG) and streptavidin (SA).
BRASSICA GAT EVENT AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF
Compositions and methods related to transgenic glyphosate tolerant Brassica plants are provided. Specifically, the present invention provides Brassica plants having a DP-073496-4 event which imparts tolerance to glyphosate. The Brassica plant harboring the DP-073496-4 event at the recited chromosomal location comprises genomic/transgene junctions within SEQ ID NO: 2 or with genomic/transgene junctions as set forth in SEQ ID NO: 12 and/or 13. The characterization of the genomic insertion site of the event provides for an enhanced breeding efficiency and enables the use of molecular markers to track the transgene insert in the breeding populations and progeny thereof. Various methods and compositions for the identification, detection, and use of the event are provided.
METHOD FOR ACQUIRING AUXILIARY INFORMATION
The present invention provides a method for acquiring auxiliary information useful to assist a diagnosis or treatment of prostate cancer. The method for acquiring auxiliary information of the present invention is a method for acquiring auxiliary information to assist a diagnosis or treatment of prostate cancer, and includes a step (C) of dividing a concentration value of a prostate specific antigen having a β-N-acetylgalactosamine residue at a non-reducing terminal of a sugar chain, contained in a sample derived from a living body, by a volume value of prostate of the living body to calculate the concentration value of the GalNAc-PSA per prostate volume.